|
Apr 25
|
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Apr 25
|
2 Fantastic Growth Stocks to Buy Right Now
|
|
Apr 25
|
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
|
|
Apr 24
|
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
|
|
Apr 23
|
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
|
|
Apr 23
|
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
|
|
Apr 23
|
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
|
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|
|
Apr 22
|
Making Sense of Amazon CEO Andy Jassy's Latest Letter
|
|
Apr 22
|
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
|
|
Apr 22
|
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
|
|
Apr 20
|
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
|
|
Apr 20
|
3 Relatively Safe Growth Stocks You Can Buy and Hold
|
|
Apr 20
|
3 Biotech Stocks Set to Double by 2028
|
|
Apr 19
|
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
|
|
Apr 19
|
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
|
|
Apr 19
|
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
|
|
Apr 18
|
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
|
|
Apr 18
|
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
|
|
Apr 18
|
Vertex begins bid for US approval of non-opioid painkiller
|